|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6886 | |
| A61K 31/519 |
| (11) | Number of the document | 3354753 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18160989.2 |
| Date of filing the European patent application | 2010-04-05 | |
| (97) | Date of publication of the European application | 2018-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-12 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 16713609 P | 2009-04-06 | US |
| (72) |
WOLFGANG, Curt, US
POLYMEROPOULOS, Mihael, H, US
|
| (73) |
Vanda Pharmaceuticals Inc.,
2200 Pennsylvania Avenue Suite 300-E, Washington, DC 20037,
US
|
| (54) | METHOD OF TREATMENT BASED ON POLYMORPHISMS OF THE KCNQ1 GENE |
| METHOD OF TREATMENT BASED ON POLYMORPHISMS OF THE KCNQ1 GENE |